Hair Loss in Women: Female Androgenetic Alopecia and Female Pattern Hair Loss
November 2011
female androgenetic alopecia female pattern hair loss androgens parietal area frontovertical area topical minoxidil systemic antiandrogenic therapy cyproterone acetate drospirenone spironolactone flutamide finasteride dutasteride adrenal hyperandrogenism ovarian hyperandrogenism polycystic ovary syndrome postmenopausal alopecia FAGA FPHL Rogaine Propecia
TLDR The document concludes that hair loss in women can be treated with topical treatments or hormone therapy depending on the cause.
The document from 2011 discusses hair loss in women, specifically female androgenetic alopecia (FAGA) and female pattern hair loss (FPHL). FAGA is associated with an increase in androgens and typically begins with a diffuse loss of hair from the parietal or frontovertical areas. FPHL is diagnosed through clinical history, examination, and laboratory tests. Treatment for FPHL includes topical minoxidil 2-5% twice daily. If FAGA is associated with high levels of androgens, systemic antiandrogenic therapy is needed. This can include cyproterone acetate, drospirenone, spironolactone, flutamide, finasteride, and dutasteride. Other conditions such as adrenal and ovarian hyperandrogenism, polycystic ovary syndrome, and postmenopausal alopecia also have specific treatments. Weight loss was noted to improve hair loss in hyperandrogenic women.
